Alpha 2.0
Login Register
» Authors » Chiara Veronesi

Chiara Veronesi

Explore the profile of Chiara Veronesi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 36
Citations 165
Followers 0
Related Specialties
Cardiology & Vascular Diseases
General Medicine
Health Services
Top 10 Co-Authors
Luca Degli Esposti
Valentina Perrone
Melania Dovizio
Stefano Buda
Elisa Giacomini
Margherita Andretta
Fausto Bartolini
Fulvio Ferrante
Davide Re
Stefania DellOrco
Published In
Clinicoecon Outcomes Res
Adv Ther
High Blood Press Cardiovasc Prev
Vasc Health Risk Manag
Curr Med Res Opin
Affiliations
Soon will be listed here.
Recent Articles
1.
Drug Utilization of Rifaximin-α in Patients with Hepatic Encephalopathy: Evidence from Real Clinical Practice in Italy
Perrone V, Usala M, Veronesi C, Cappuccilli M, Degli Esposti L
Medicina (Kaunas) . 2025 Feb; 61(2). PMID: 40005338
: This analysis described rifaximin utilization in Italian patients with hepatic encephalopathy (HE). Although rifaximin is effective in preventing HE relapses, therapeutic management and prescriptive attitudes might be improved. :...
2.
The Economic Burden of Herpes Zoster in Individuals Aged 50 Years or Older and Those With Underlying Conditions in Italy
Zarkadoulas E, Comparoni S, Freguja R, Santacroce R, Dovizio M, Veronesi C, et al.
Open Forum Infect Dis . 2025 Jan; 12(1):ofae738. PMID: 39877401
Background: Risk of herpes zoster (HZ) infection increases with age and immunosuppression. We estimated the impact of HZ and post-herpetic neuralgia (PHN) on direct costs and health care resource utilization...
3.
Mortality, Clinical Complications, and Healthcare Resource Utilization Associated with Managing Transfusion-Dependent β-Thalassemia and Sickle Cell Disease with Recurrent Vaso-occlusive Crises in Italy
Udeze C, Dovizio M, Veronesi C, Degli Esposti L, Li N, Dang T, et al.
Pharmacoecon Open . 2024 Oct; 9(1):115-124. PMID: 39468000
Objective: To examine the clinical burden and healthcare resource utilization (HCRU) among patients with transfusion-dependent β-thalassemia (TDT) and patients with sickle cell disease (SCD) with recurrent vaso-occlusive crises (VOCs) in...
4.
A real-world analysis of adherence, biochemical outcomes, and healthcare costs in patients treated with rosuvastatin/ezetimibe as single-pill combination vs. free combination in Italy
Zambon A, Liberopoulos E, Dovizio M, Veronesi C, Degli Esposti L, de Isla L
Eur Heart J Open . 2024 Sep; 4(5):oeae074. PMID: 39310723
Aims: To compare medication adherence, lipid goal attainment, and healthcare costs between patients receiving a single-pill combination (SPC) vs. a free combination treatment (FCT) of rosuvastatin/ezetimibe (ROS/EZE) in Italy. Methods...
5.
Healthcare resource utilization and related cost among hospitalized patients with prurigo nodularis: a retrospective cohort study using Italian health claims data
Bahloul D, Ronci G, Isaman D, Pedone M, Degli Esposti L, Giacomini E, et al.
Ital J Dermatol Venerol . 2024 Sep; 159(5):475-483. PMID: 39250164
Background: Prurigo nodularis (PN) is a chronic, inflammatory skin disease characterized by intense itch. Little evidence exists on the burden of PN in Italy. This real-world analysis aimed to investigate...
6.
A retrospective Italian analysis on the characteristics of invasive fungal infections in the intensive care unit setting: CHARTER-IFI study
Viale P, Mirandola S, Natalini C, Degli Esposti L, Dovizio M, Veronesi C, et al.
Mycoses . 2024 Aug; 67(8):e13779. PMID: 39101705
Background: Invasive fungal infections (IFI), prevalent in critically ill ICU patients, have gained attention due to post-COVID-19 epidemiological shifts. Notably, COVID-19-associated aspergillosis and candidiasis pose significant risks. WHO recognises key...
7.
Differential Adherence to Free and Single-Pill Combination of Rosuvastatin/Ezetimibe: Findings from a Real-World Analysis in Italy
de Isla L, Liberopoulos E, Dovizio M, Veronesi C, Degli Esposti L, Zambon A
Adv Ther . 2024 Jul; 41(8):3407-3418. PMID: 38963586
Introduction: Adherence to cardiovascular drug treatment can significantly benefit from a reduced pill burden, but data on this matter derived from real-life settings are currently scanty. This analysis assessed the...
8.
Real-World Treatment Patterns and Healthcare Resource Use for Ulcerative Colitis and Crohn's Disease in Italy
Dovizio M, Hartz S, Buzzoni C, Redondo I, Nedeljkovic Protic M, Birra D, et al.
Adv Ther . 2024 Apr; 41(6):2282-2298. PMID: 38619721
Introduction: Real-world data are used to inform decision-makers and optimise therapeutic management for patients with ulcerative colitis (UC) and Crohn's disease (CD). We analysed data on the epidemiology (by using...
9.
Clinical and economic burden of respiratory syncytial virus in children aged 0-5 years in Italy
Dovizio M, Veronesi C, Bartolini F, Cavaliere A, Grego S, Pagliaro R, et al.
Ital J Pediatr . 2024 Mar; 50(1):57. PMID: 38528616
Background: Respiratory syncytial virus (RSV) is among the leading causes of hospitalization due to lower respiratory tract infections (LRTIs) in children younger than 5 years worldwide and the second cause...
10.
A Retrospective Observational Real-Word Analysis of the Adherence, Healthcare Resource Consumption and Costs in Patients Treated with Bisoprolol/Perindopril as Single-Pill or Free Combination
Masi S, Kobalava Z, Veronesi C, Giacomini E, Degli Esposti L, Tsioufis K
Adv Ther . 2023 Oct; 41(1):182-197. PMID: 37864626
Introduction: The present real-world analysis aims to compare the drug utilization, hospitalizations and direct healthcare costs related to the use of single-pill combination (SPC) or free-equivalent combination (FEC) of perindopril...